// App-Quantinova.ai

: Laboratory Measurement of Rivaroxaban Using Anti‐factor Xa Assays in Patients with Cancer‐associated Thrombosis

Researchers

Presenter

  • E.-H. Koh

Principal Investigators

  • H. Shin

  • G.-W. Lee

  • H.-N. Song

Medical Centers

  • Gyeongsang National University College of Medicine and Gyeongsang National University Hospital, Department of Laboratory Medicine, Jinju, Korea, Republic of

  • Gyeongsang National University College of Medicine and Gyeongsang National University Hospital, Department of Laboratory Medicine, Jinju, Korea, Republic of

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • Catalase

Drug/Treatment

  • rivaroxaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved